Addex Therapeutics Stock Forward View
| ADXN Stock | USD 7.66 0.58 7.04% |
Addex Stock outlook is based on your current time horizon. Although Addex Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Addex Therapeutics' systematic risk associated with finding meaningful patterns of Addex Therapeutics fundamentals over time.
As of today, the RSI of Addex Therapeutics' share price is approaching 45. This suggests that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Addex Therapeutics, making its price go up or down. Momentum 45
Impartial
Oversold | Overbought |
Wall Street Target Price 30 | Quarterly Revenue Growth (0.15) |
Using Addex Therapeutics hype-based prediction, you can estimate the value of Addex Therapeutics from the perspective of Addex Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Addex Therapeutics on the next trading day is expected to be 7.49 with a mean absolute deviation of 0.27 and the sum of the absolute errors of 16.19. Addex Therapeutics after-hype prediction price | USD 7.75 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Addex Therapeutics to cross-verify your projections. Addex Therapeutics Additional Predictive Modules
Most predictive techniques to examine Addex price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Addex using various technical indicators. When you analyze Addex charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Addex Therapeutics Cash Forecast
Forecasting financial indicators like cash flow involves analysts applying various statistical methods, techniques, and algorithms. These tools reveal hidden trends within the Addex Therapeutics' financial statements to estimate their effects on upcoming price movements.
Cash | First Reported 2009-12-31 | Previous Quarter 2.3 M | Current Value 2.2 M | Quarterly Volatility 19.4 M |
Addex Therapeutics Naive Prediction Price Forecast For the 3rd of February
Given 90 days horizon, the Naive Prediction forecasted value of Addex Therapeutics on the next trading day is expected to be 7.49 with a mean absolute deviation of 0.27, mean absolute percentage error of 0.12, and the sum of the absolute errors of 16.19.Please note that although there have been many attempts to predict Addex Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Addex Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Addex Therapeutics Stock Forecast Pattern
| Backtest Addex Therapeutics | Addex Therapeutics Price Prediction | Research Analysis |
Addex Therapeutics Forecasted Value
In the context of forecasting Addex Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Addex Therapeutics' downside and upside margins for the forecasting period are 2.48 and 12.51, respectively. We have considered Addex Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Addex Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Addex Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.0183 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.2654 |
| MAPE | Mean absolute percentage error | 0.0328 |
| SAE | Sum of the absolute errors | 16.1891 |
Predictive Modules for Addex Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Addex Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Addex Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Addex Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Addex Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Addex Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Addex Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Addex Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Addex Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Addex Therapeutics' historical news coverage. Addex Therapeutics' after-hype downside and upside margins for the prediction period are 2.73 and 12.77, respectively. We have considered Addex Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Addex Therapeutics is somewhat reliable at this time. Analysis and calculation of next after-hype price of Addex Therapeutics is based on 3 months time horizon.
Addex Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Addex Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Addex Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Addex Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.21 | 5.02 | 0.09 | 0.03 | 7 Events / Month | 4 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
7.66 | 7.75 | 1.17 |
|
Addex Therapeutics Hype Timeline
Addex Therapeutics is presently traded for 7.66. The entity has historical hype elasticity of 0.09, and average elasticity to hype of competition of -0.03. Addex is anticipated to increase in value after the next headline, with the price projected to jump to 7.75 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 1.17%, whereas the daily expected return is presently at -0.21%. The volatility of related hype on Addex Therapeutics is about 3637.68%, with the expected price after the next announcement by competition of 7.63. The company reported the previous year's revenue of 404.1 K. Net Income was 7.06 M with loss before overhead, payroll, taxes, and interest of (525.65 K). Given the investment horizon of 90 days the next anticipated press release will be in about 7 days. Check out Historical Fundamental Analysis of Addex Therapeutics to cross-verify your projections.Addex Therapeutics Related Hype Analysis
Having access to credible news sources related to Addex Therapeutics' direct competition is more important than ever and may enhance your ability to predict Addex Therapeutics' future price movements. Getting to know how Addex Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Addex Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CDIO | Cardio Diagnostics Holdings | (0.07) | 6 per month | 0.00 | (0.17) | 8.44 | (12.50) | 38.04 | |
| BCLI | Brainstorm Cell Therapeutics | (0.01) | 6 per month | 0.00 | (0.03) | 9.09 | (6.67) | 24.01 | |
| MTNB | Matinas BioPharma Holdings | (0.35) | 8 per month | 0.00 | (0.15) | 11.67 | (10.67) | 39.32 | |
| RADX | Radiopharm Theranostics Limited | (0.02) | 22 per month | 7.78 | 0.05 | 7.44 | (7.58) | 193.18 | |
| IBO | Impact BioMedical | 0.01 | 6 per month | 0.00 | (0.01) | 8.00 | (7.41) | 61.57 | |
| QNRX | Quoin Pharmaceuticals Ltd | (0.40) | 9 per month | 0.00 | (0.04) | 18.69 | (11.19) | 77.47 | |
| TCRT | Alaunos Therapeutics | (0.18) | 7 per month | 5.52 | (0) | 9.61 | (10.55) | 24.31 | |
| NRSN | Neurosense Therapeutics | 0.01 | 9 per month | 0.00 | (0.03) | 12.82 | (7.48) | 34.62 | |
| NBY | NovaBay Pharmaceuticals | (0.37) | 9 per month | 13.27 | 0.12 | 33.70 | (24.76) | 158.53 | |
| ADIL | Adial Pharmaceuticals | 0.00 | 6 per month | 0.00 | (0.20) | 5.56 | (6.25) | 16.67 |
Other Forecasting Options for Addex Therapeutics
For every potential investor in Addex, whether a beginner or expert, Addex Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Addex Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Addex. Basic forecasting techniques help filter out the noise by identifying Addex Therapeutics' price trends.Addex Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Addex Therapeutics stock to make a market-neutral strategy. Peer analysis of Addex Therapeutics could also be used in its relative valuation, which is a method of valuing Addex Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Addex Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Addex Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Addex Therapeutics shares will generate the highest return on investment. By undertsting and applying Addex Therapeutics stock market strength indicators, traders can identify Addex Therapeutics entry and exit signals to maximize returns.
Addex Therapeutics Risk Indicators
The analysis of Addex Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Addex Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting addex stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.72 | |||
| Standard Deviation | 5.01 | |||
| Variance | 25.11 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Addex Therapeutics
The number of cover stories for Addex Therapeutics depends on current market conditions and Addex Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Addex Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Addex Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Addex Therapeutics Short Properties
Addex Therapeutics' future price predictability will typically decrease when Addex Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Addex Therapeutics often depends not only on the future outlook of the potential Addex Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Addex Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 817.6 K | |
| Cash And Short Term Investments | 3.3 M |
Check out Historical Fundamental Analysis of Addex Therapeutics to cross-verify your projections. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Will Biotechnology sector continue expanding? Could Addex diversify its offerings? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Addex Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (9.43) | Revenue Per Share | Quarterly Revenue Growth (0.15) | Return On Assets | Return On Equity |
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Addex Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Addex Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Addex Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.